TPG-Affiliated 10% Owners Sell $145M in LifeStance Health Stock
Summary
TPG GP A, LLC, James G. Coulter, and Jon Winkelried, all 10% owners of LifeStance Health Group, Inc., reported the sale of over 20.6 million shares for approximately $145 million.
Key Events
-
Major Insider Sale
TPG GP A, LLC, James G. Coulter, and Jon Winkelried, all 10% owners, collectively sold 20,685,061 shares of common stock.
-
Significant Value Divested
The sale was valued at approximately $145,002,278, with shares transacting at $7.01 each on March 2, 2026.
-
Part of Secondary Offering
This transaction is understood to be part of the secondary offering by selling stockholders that closed on March 2, 2026, where 25 million shares were sold.
Analysis
This significant sale by TPG-affiliated 10% owners, totaling over $145 million, represents a substantial reduction in their stake. While this transaction is understood to be part of the previously announced secondary offering that closed on March 2, 2026, it still signals a notable divestment by a major institutional investor. Investors should monitor the impact of this large share disposition on market sentiment and liquidity, especially following the company's recent return to profitability and concurrent share repurchase program.
At the time of this filing, LFST was trading at $7.33 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.9B. The 52-week trading range was $3.74 to $8.30. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.